The phosphodiesterases (PDE) activity in human trabecular meshwork cells (H
TM-3) was investigated in this study in order to better understand the sign
al transduction pathways in the conventional outflow tract of the eye. Agon
ists (isoproterenol or nitroprusside) were used to stimulate adenylyl cycla
se and guanylyl cyclase, respectively, in the absence and presence of nonse
lective IBMX or PDES specific inhibitors E4021 (1). The subcellular distrib
ution of cAMP and cGMP PDEs was determined directly by PDE enzyme assays us
ing HTM-3 cells. Levels of cyclic nucleotides were measured in the same cel
ls by radioimmunoassay (RIA). Isoproterenol alone elevated cAMP levels, and
this response was enhanced by IBMX. Nitroprusside alone caused no increase
in basal cGMP levels but, in the presence of E4021, nitroprusside produced
significant, dose-related elevation of cGMP levels. Subcellular distributi
on experiments indicated that the greatest activity for PDEs resided in the
supernatant fraction. In conclusion, HTM-3 cells contain PDEs that degrade
both cyclic nucleotides. The PDE activities reside predominantly in the su
pernatant, but the PDE activity for degrading cGMP is more pronounced. More
over, results with E4021 suggest that PDES activity could play a critical r
ole in modulating cGMP-related activity in the trabecular meshwork.